Tumor microenvironment (Hypoxia and Hydrogen Peroxide) (Hypoxia/H2O2 TME)

The hypoxic tumor microenvironment (TME) and elevated levels of hydrogen peroxide (H2O2) are hallmark physiological features of solid tumors resulting from rapid cell proliferation and aberrant vascularization (PMID: 30214335). Hypoxia occurs when the oxygen demand of the tumor exceeds the supply, leading to the stabilization of Hypoxia-Inducible Factors (HIFs) which drive angiogenesis, glycolysis, and cell survival (PMID: 28233820). Simultaneously, cancer cells often exhibit increased production of H2O2 due to mitochondrial dysfunction and altered redox homeostasis, which promotes genomic instability and oncogenic signaling (PMID: 29435140). These environmental conditions are frequently exploited as triggers for 'stimuli-responsive' drug delivery systems, such as hypoxia-activated prodrugs (HAPs) or H2O2-responsive nanocarriers (PMID: 31161756). For example, HAPs like Evofosfamide are designed to undergo enzymatic reduction to cytotoxic species specifically in oxygen-depleted tissues, while ROS-responsive systems utilize oxidative cleavage to release therapeutic payloads (PMID: 26153495, PMID: 27532385). While these strategies aim to improve the therapeutic index of chemotherapy, challenges remain regarding the spatial heterogeneity of these conditions within a single tumor and the potential for off-target activation in other physiological niches.

Other names

Hypoxic tumor microenvironmentOxidative tumor microenvironmentH2O2-rich TMETumor hypoxiaTumor redox environment

Bioactivation via enzymatic reduction in low-oxygen conditions (hypoxia) or oxidative chemical transformation by hydrogen peroxide to release active therapeutic agents or imaging probes.